LEWIS et al., 1940 - Google Patents
The effect of the adrenal cortex on carbohydrate metabolismLEWIS et al., 1940
- Document ID
- 13504419921158615987
- Author
- LEWIS R
- Kuhlman D
- DELBUE C
- KOEPF G
- THORN G
- Publication year
- Publication venue
- Endocrinology
External Links
Snippet
THE ROLE of the adrenal cortex in promoting the formation of carbohydrate from protein sources has been demonstrated in experimental animals (1). Recently it has also been shown that adrenal cortical hormone therapy had a striking effect in regulating carbohydrate …
- 230000000694 effects 0 title abstract description 19
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S514/00—Drug, bio-affecting and body treating compositions
- Y10S514/866—Diabetes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LEWIS et al. | The effect of the adrenal cortex on carbohydrate metabolism | |
| McCance | Medical problems in mineral metabolism | |
| De Bodo | The antidiuretic action of morphine, and its mechanism | |
| Thorn et al. | Carbohydrate metabolism in Addison's disease | |
| Raisz et al. | The effects of cortisone and hydrocortisone on water diuresis and renal function in man | |
| Ingle | Problems relating to the adrenal cortex | |
| US5006551A (en) | Composition for destroying malignant tumors | |
| Clutton et al. | Studies in synthetic immunochemistry: Preparation and antigenic properties of thyroxyl derivatives of proteins, and physiological effects of their antisera | |
| McKee et al. | Phlorhizin glucosuria | |
| McSwiney et al. | Metabolic effects of three testosterone derivatives including 17α-ethyl-19-nortestosterone | |
| Stormont et al. | The effect of prednisone and amphenone on fluid and electrolyte balance and on aldosterone excretion of patients with cirrhosis and ascites | |
| TEABEAUT et al. | Hypokaliemic, hypochloremic alkalosis in cushing's syndrome. Observations on the effects of treatment with potassium chloride and testosterone | |
| WEBSTER | Adrenal cortex in liver disease | |
| WILLIAMS et al. | Thiouracils and thioureas: Comparisons of the absorption, distribution, destruction and excretion | |
| Beher et al. | Effects of psyllium hydrocolloid on bile acid metabolism in normal and hypophysectomized rats | |
| Menguy | Regulation of gastric mucus secretion | |
| AXELROD et al. | Insulin resistance | |
| Macbryde et al. | Pork adrenal-cortex extract: effect upon carbohydrate metabolism and work capacity in Addison's disease | |
| DESPOPOULOS et al. | Probenecid in hypoparathyroidism: absence of phosphaturic response | |
| Dury | Effect of intravenous glucose on tissue water and ionic content and moderation of potassium plethora with epinephrine and insulin pretreatment | |
| Gray | The treatment of diabetes mellitus with insoluble insulin compounds | |
| INGLE | THE DIABETOGENIC EFFECT OF DIETHYLSTILBESTROLIN ADRENALECTOMIZED HYPOPHYSECTOMIZED-PARTIALLYDEPANCREATIZED RATS | |
| NAKAMURA et al. | Prolonged neuromuscular blockade following trimetaphan infusion: A case report and in vitro study of cholinesterase inhibition | |
| Armstrong | Effect of testosterone propionate in a patient with diabetes mellitus and Addison's disease | |
| US4521425A (en) | Agents affecting the production of hormones in living mammals |